Jump to main content
Jump to site search

All chapters
Previous chapter Next chapter

CHAPTER 12

Neuropeptide Receptors: Novel Therapeutic Targets for Depression and Anxiety Disorders

Numerous neuropeptides have recently attracted interest as novel targets for drug discovery for the treatment of depression and anxiety based on the important roles that these proteins play in regulating stress responses. Neuropeptides exert their effects through specific receptors, most of which belong to the G-protein coupled receptor superfamily. A series of neurochemical and behavioural studies utilizing pharmacological tools and genetically engineered animals have elucidated the role of each receptor subtype in depression and anxiety. In addition, clinical studies have been conducted using selective antagonists for several receptor subtypes. In particular, neuropeptides that regulate two important stress-related pathways, HPA axis activity and reward activity, are of interest as novel approaches for the treatment of depression and anxiety.

Publication details


Print publication date
02 Nov 2012
Copyright year
2012
Print ISBN
978-1-84973-365-6
PDF eISBN
978-1-84973-494-3
From the book series:
Drug Discovery